openPR Logo
Press release

Clinical Trials & Results of Thymic Carcinoma Therapeutics | Merck, NMS Group - Nerviano Medical Sciences, Tiziana Life Sciences

04-19-2019 03:03 PM CET | Health & Medicine

Press release from: Thymic Carcinoma Therapeutics - Pharma Proff

Clinical Trials & Results of Thymic Carcinoma Therapeutics |

Thymic carcinoma, also known as thymomas, is a rare type of cancer that forms in the cells present in the outside surface of the thymus. Thymus is a small organ that lies in the upper chest under the breastbone. It is a part of the lymph system and produces certain types of white blood cells that helps the body to fight against infections.

Download the sample report @ https://www.pharmaproff.com/request-sample/1119

The tumor cells in a thymoma look like the normal cells of the thymus which grow slowly and rarely spread beyond the thymus.

Get the detailed analysis @ https://www.pharmaproff.com/report/thymic-carcinoma-therapeutics-pipeline-analysis

The drug candidates of thymic carcinoma disease pipeline include, but not limited to, pembrolizumab, and milciclib maleate. Some of the companies having drugs in the thymic carcinoma disease pipeline includes Merck & Co. Inc., NMS Group SpA and Tiziana Life Sciences plc.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1119

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trials & Results of Thymic Carcinoma Therapeutics | Merck, NMS Group - Nerviano Medical Sciences, Tiziana Life Sciences here

News-ID: 1711111 • Views: 686

More Releases for Thymus

Thymus Cancer Market to Witness an Outstanding Growth 2022
Thymus cancer or thyomas is a tumor formed on the outer surface of the thymus. Thymus is a small organ located in the upper chest under the breast bone and makes specific type of white blood cells which help the body fight infection. The tumor occurs at the rate of only 1.5 cases in million people each year in the United States thus being a rare type of cancer make
Thymus Cancer Market Size & Shares, Strategies and Forecast Worldwide, 2017 - 20 …
MarketResearchReports.Biz has recently added a research document to their roster titled “Thymus Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025”. The objectives of this study are as follows: To define, describe, and forecast the "Thymus Cancer" market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges) To analyze micromarkets with
Thymus Cancer Market Will Generate New Growth Opportunities by 2025
Thymus is an irregular shape gland which is located under the breastbone (sternum) in upper chest. The organ is divided into two halves known as lobes and is made up of many small bumps called as lobules. Thymus plays an important role in maintaining the body’s immune system. During fetal development and childhood thymus gland is involved in the production and maturation of T lymphocytes (T cells). T cells are
Thymus Cancer Market: Future market projections for forthcoming years
Thymus is an irregular shape gland which is located under the breastbone (sternum) in upper chest. The organ is divided into two halves known as lobes and is made up of many small bumps called as lobules. Thymus plays an important role in maintaining the body’s immune system. During fetal development and childhood thymus gland is involved in the production and maturation of T lymphocytes (T cells). T cells are
Thymus Cancer Market: Future Demand, Market Analysis & Outlook to 2022
Thymus cancer or thyomas is a tumor formed on the outer surface of the thymus. Thymus is a small organ located in the upper chest under the breast bone and makes specific type of white blood cells which help the body fight infection. The tumor occurs at the rate of only 1.5 cases in million people each year in the United States thus being a rare type of cancer make
Thymus Cancer Market Technological breakthroughs 2025
Thymus is an irregular shape gland which is located under the breastbone (sternum) in upper chest. The organ is divided into two halves known as lobes and is made up of many small bumps called as lobules. Thymus plays an important role in maintaining the body’s immune system. During fetal development and childhood thymus gland is involved in the production and maturation of T lymphocytes (T cells). T cells are